A Study of iPS Cell-derived Cardiomyocyte Spheroids (HS-001) in Patients With Heart Failure (LAPiS Study)
Clinical trial NCT04945018 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04945018
- Sponsor
- Heartseed Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-19
- Primary completion
- 2025-07-31
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.